Table 2 Rectal swab culture results in patients with IBD and non-IBD patients in a tertiary center in Rzeszow (Southern Poland) along with cultured microorganisms (January 2017—December 2019)
Number of rectal swabs, n | Positive results, n/% | Cultured microorganisms | Number | Susceptibility of the cultured microorganismsa | % in relation to all collected samples | % in relation to positive results |
|---|---|---|---|---|---|---|
Patients with IBD | ||||||
249 | 20/9.8 | Candida albicans | 14 | AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | 5.6 | 70.0 |
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(r) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(r) | ||||||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
Candida sp. non albicans | 2 | AmB(s), CAS(s), FLU(s), MYC(s), VO(s) | 0.8 | 10.0 | ||
AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | ||||||
Candida glabrata | 2 | AmB(s), CAS(s), FLU(s), MYC(s) | 0.8 | 10.0 | ||
AmB(s), CAS(s), FLU(s), MYC(s) | ||||||
Candida lusitaniae | 1 | AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | 0.4 | 5.0 | ||
Candida kefyr | 1 | AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | 0.4 | 5.0 | ||
Non-IBD patients | ||||||
110 | 5/4.54 | Candida albicans | 1 | AmB(s), CAS(s), FLU(s), AFY(s), MYC(s), VO(s) | 0.91 | 20.0 |
Candida glabrata | 2 | AmB(s), CAS(s), FLU(s), MYC(s) | 1.82 | 40.0 | ||
AmB(s), CAS(s), FLU(r), MYC(s) | ||||||
Salmonella enterica | 2 | AK(s), SAM(s), FEP(s), CTX(s), CAZ(s), CXM(s), CIP(s), CT(s), ETP(s), GM(s), IPM(s), MEM(s), TZP(s), TGC(s), SXT(s) | 1.82 | 40.0 | ||
AK(s), SAM(s), FEP(s), CTX(s), CAZ(s), CXM(s), CIP(r), CT(s), ETP(s), GM(s), IPM(s), MEM(s), TZP(s), TGC(s), SXT(s) | ||||||